G. Soler

1.4k total citations
22 papers, 608 citations indexed

About

G. Soler is a scholar working on Oncology, Surgery and Small Animals. According to data from OpenAlex, G. Soler has authored 22 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 5 papers in Surgery and 4 papers in Small Animals. Recurrent topics in G. Soler's work include Colorectal Cancer Surgical Treatments (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Diagnosis and Treatment (5 papers). G. Soler is often cited by papers focused on Colorectal Cancer Surgical Treatments (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Diagnosis and Treatment (5 papers). G. Soler collaborates with scholars based in Spain, Luxembourg and Denmark. G. Soler's co-authors include C. Soler, Iván Serra, José Ignacio Redondo, Laura Gil, Mónica Rubio, F. Losa Gaspà, Rafael Morales‐Barrera, Diégo Tosi, G. Baciarello and L. Chaigneau and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Diseases of the Colon & Rectum.

In The Last Decade

G. Soler

20 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Soler Spain 12 279 196 146 121 118 22 608
Atilla Gürses Türkiye 18 157 0.6× 8 0.0× 372 2.5× 572 4.7× 65 0.6× 53 870
Jin Lee South Korea 15 96 0.3× 27 0.1× 300 2.1× 189 1.6× 59 0.5× 64 689
Kemal Bakır Türkiye 12 78 0.3× 7 0.0× 162 1.1× 231 1.9× 96 0.8× 62 533
Bernard Detroz Belgium 13 180 0.6× 7 0.0× 619 4.2× 118 1.0× 15 0.1× 39 808
Roberta Polverosi Italy 14 171 0.6× 9 0.0× 186 1.3× 295 2.4× 24 0.2× 50 544
Shuji Haraguchi Japan 13 140 0.5× 5 0.0× 250 1.7× 399 3.3× 50 0.4× 69 641
Benjamin Ng Australia 8 75 0.3× 13 0.1× 169 1.2× 401 3.3× 50 0.4× 14 592
Samer Al‐Khudari United States 12 124 0.4× 13 0.1× 285 2.0× 124 1.0× 20 0.2× 49 509
Mendel Glazer Israel 8 261 0.9× 12 0.1× 106 0.7× 389 3.2× 15 0.1× 11 753
Bartholomäus Böhm Germany 10 748 2.7× 14 0.1× 941 6.4× 540 4.5× 25 0.2× 12 1.3k

Countries citing papers authored by G. Soler

Since Specialization
Citations

This map shows the geographic impact of G. Soler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Soler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Soler more than expected).

Fields of papers citing papers by G. Soler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Soler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Soler. The network helps show where G. Soler may publish in the future.

Co-authorship network of co-authors of G. Soler

This figure shows the co-authorship network connecting the top 25 collaborators of G. Soler. A scholar is included among the top collaborators of G. Soler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Soler. G. Soler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capdevila, Jaume, Ismael Macías, Ignacio Escobar, et al.. (2023). Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. Journal of Clinical Oncology. 41(16_suppl). TPS3624–TPS3624.
2.
Losa, Ferrán, Isaura Fernández, L. Iglesias, et al.. (2022). SEOM—GECOD clinical guideline for unknown primary cancer (2021). Clinical & Translational Oncology. 24(4). 681–692. 5 indexed citations
3.
Losa, Ferrán, et al.. (2021). Short-course radiotherapy in stage IV rectal cancer with resectable disease. Clinical & Translational Oncology. 23(12). 2482–2488.
4.
Batlle, Jaime Feliú, Álvaro Pinto, Enrique Espinosa, et al.. (2020). Development and validation of an early death risk score for older patients treated with chemotherapy for cancer.. Journal of Clinical Oncology. 38(15_suppl). 12030–12030. 1 indexed citations
5.
Losa, Ferrán, et al.. (2020). Short-Course Radiotherapy in Locally Advanced Rectal Cancer. Clinical and Translational Gastroenterology. 11(6). e00162–e00162. 8 indexed citations
6.
7.
Feliú, Jaime, Antonieta Salud, Vicente Alonso, et al.. (2018). First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial.. Journal of Clinical Oncology. 36(15_suppl). TPS3618–TPS3618. 2 indexed citations
8.
Grávalos, Cristina, Alfredo Carrato, Mercedes Rodríguez-Garrote, et al.. (2018). A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 17(2). e323–e329. 15 indexed citations
9.
Soler, G., Irune Ruiz, Silvia Vázquez, et al.. (2018). Detection of frailty in elderly colorectal càncer patients: Is G8 a good screening tool?. Annals of Oncology. 29. viii191–viii191. 1 indexed citations
10.
Navarro-Martín, Arturo, et al.. (2017). Stereotactic body radiotherapy: A promising approach for colorectal lung oligometastases. Annals of Oncology. 28. iii117–iii117. 2 indexed citations
11.
Losa, Ferrán, G. Soler, Antonio Casado, et al.. (2017). SEOM clinical guideline on unknown primary cancer (2017). Clinical & Translational Oncology. 20(1). 89–96. 41 indexed citations
12.
Velasco, Roser, Cristina Santos, G. Soler, et al.. (2016). Serum micronutrients and prealbumin during development and recovery of chemotherapy‐induced peripheral neuropathy. Journal of the Peripheral Nervous System. 21(3). 134–141. 11 indexed citations
13.
García, Margarita, Cristina Santos, Valentín Navarro, et al.. (2015). Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer. 15(1). 59–59. 16 indexed citations
14.
Soler, C., et al.. (2012). Sedative effects of dexmedetomidine, dexmedetomidine–pethidine and dexmedetomidine–butorphanol in cats. Journal of Veterinary Pharmacology and Therapeutics. 36(3). 222–228. 38 indexed citations
15.
Santos, Cristina, Adriana López‐Doriga, M. Navarro, et al.. (2012). Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal Disease. 15(4). 414–422. 33 indexed citations
16.
Redondo, José Ignacio, et al.. (2012). Retrospective study of the prevalence of postanaesthetic hypothermia in dogs. Veterinary Record. 171(15). 374–374. 72 indexed citations
17.
Redondo, José Ignacio, et al.. (2011). Retrospective study of the prevalence of postanaesthetic hypothermia in cats. Veterinary Record. 170(8). 206–206. 78 indexed citations
18.
Redondo, José Ignacio, et al.. (2007). Normal Values and Incidence of Cardiorespiratory Complications in Dogs During General Anaesthesia. A Review of 1281 Cases. Journal of Veterinary Medicine Series A. 54(9). 470–477. 74 indexed citations
19.
Arriola, Edurne, Matilde Navarro, David Parés, et al.. (2006). Imaging Techniques Contribute to Increased Surgical Rescue of Relapse in the Follow-Up of Colorectal Cancer. Diseases of the Colon & Rectum. 49(4). 478–484. 30 indexed citations
20.
Galán, Maica, Núria Viñolas, Dolors Colomer, et al.. (2003). Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.. PubMed. 22(5). 2877–84. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atilla Gürses Breakdown of academic impact, for papers by Jin Lee Breakdown of academic impact, for papers by Kemal Bakır Breakdown of academic impact, for papers by Bernard Detroz Breakdown of academic impact, for papers by Roberta Polverosi Breakdown of academic impact, for papers by Shuji Haraguchi Breakdown of academic impact, for papers by Benjamin Ng Breakdown of academic impact, for papers by Samer Al‐Khudari Breakdown of academic impact, for papers by Mendel Glazer Breakdown of academic impact, for papers by Bartholomäus Böhm
Rankless by CCL
2026